CoChat

Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency

Open access
Kurosawa, Yuko, DeGrauw, Ton J., Lindquist, Diana M., Blanco, Victor M., Pyne-Geithman, Gail J., Daikoku, Takiko, Chambers, James B., Benoit, Stephen C., Clark, Joseph F. · 2012 · Journal of Clinical Investigation

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

The second-largest cause of X-linked mental retardation is a deficiency in creatine transporter (CRT; encoded by SLC6A8), which leads to speech and language disorders with severe cognitive impairment. This syndrome, caused by the absence of creatine in the brain, is currently untreatable because CRT is required for creatine entry into brain cells. Here, we developed a brain-specific Slc6a8 knockout mouse (Slc6a8-/y) as an animal model of human CRT deficiency in order to explore potential therapies for this syndrome. The phenotype of the Slc6a8-/y mouse was comparable to that of human patients. We successfully treated the Slc6a8-/y mice with the creatine analog cyclocreatine. Brain cyclocreatine and cyclocreatine phosphate were detected after 9 weeks of cyclocreatine treatment in Slc6a8-/y mice, in contrast to the same mice treated with creatine or placebo. Cyclocreatine-treated Slc6a8-/y mice also exhibited a profound improvement in cognitive abilities, as seen with novel object recognition as well as spatial learning and memory tests. Thus, cyclocreatine appears promising as a potential therapy for CRT deficiency.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci59373

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Hoosein, 1995, Anticancer Res., 15, 1339

Cited by

See all 100

Metadata

Authors
Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F.
Affiliations
  • University of Cincinnati (US)
  • Cincinnati Children's Hospital Medical Center (US)
Corresponding author
Clark, Joseph F.
Venue
Journal of Clinical Investigation
Published
2012-08-01
Volume
122
Issue
8
Pages
2837-2846
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2082741813
Cited by
98
References
62
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 11 · 2022: 3 · 2021: 14 · 2020: 8 · 2019: 8 · 2018: 4 · 2017: 6 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 10 · 2012: 2
FWCI
5.54
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cincinnati Children's Hospital Medical Center
  • Tokyo Medical and Dental University
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS049172, NS049172)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
creatine transporter deficiency, SLC6A8, cyclocreatine, X-linked intellectual disability, cognitive impairment, novel object recognition, spatial learning and memory
MeSH terms
Animals, Base Sequence, Brain, Cognition, Cognition Disorders, Creatinine, Disease Models, Animal, Female, Humans, Learning, Male, Memory, Mice, Inbred C57BL, Models, Neurological, Phosphocreatine, DNA Primers, Mice, Knockout, Membrane Transport Proteins, Mental Retardation, X-Linked, X-Linked Intellectual Disability, Imidazolidines, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.